ARTICLE
10 February 2022

Vaccination Certificate Validity Changed

EG
Envoy Global, Inc.

Contributor

Envoy Global, Inc. logo
Founded in 1998, Envoy is a global immigration services provider offering the only immigration management platform that makes it seamless for companies to hire and manage an international workforce. We combine expert legal representation and proprietary technology to bring efficiency and transparency to the immigration process for employers and employees.
Beginning 8 Feb. 2022, the government of the Netherlands will reduce the validity period of the European Union (EU) COVID-19 vaccination certificate from 12 months to nine months (270 days).
Netherlands Coronavirus (COVID-19)
To print this article, all you need is to be registered or login on Mondaq.com.

Key Points

  • Reduced validity period of the EU COVID-19 vaccination certificate

Overview

Beginning 8 Feb. 2022, the government of the Netherlands will reduce the validity period of the European Union (EU) COVID-19 vaccination certificate from 12 months to nine months (270 days). After nine months, EU vaccination certificate holders will be required to obtain a booster dose for the coronavirus entry pass (CTB) to remain valid for travel to the Netherlands.

The government reduced the validity period of the CTB to nine months with the aim of aligning with European Commission recommendations. The CTB is required for use when entering certain businesses or hosting events in the Netherlands.

What are the Changes?

The government of the Netherland's announced that it will reduce the validity period of the EU COVID-19 vaccination certificate for travel to the Netherlands in order to better align the requirements with recommendations from the European Commission on the validity period of the EU COVID-19 vaccination certificate.

Looking Ahead

The government of the Netherlands has yet to determine a validity period for the CTB for individuals who have received a booster dose. Continue to check the government of the Netherland's website and Envoy's website for the latest updates and information.

Originally published 8 February, 2022

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More